Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 4,178,345 | reported | 29 Dec 2025 | tx 218+10,181,954−7,022,461 |
| THERMOGENESIS CORP | 122,750 | reported | 01 Jul 2014 | tx 26+327,000−134,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 26,334 | — | |
| 29 Dec 2025 | TAX_WITHHOLDING | CATALYST PHARMACEUTICALS, INC. | 6,786 | — | |
| 29 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 26,334 | 0.00 USD | deriv |
| 08 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 3,534 | — | |
| 08 Dec 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 3,534 | 0.00 USD | deriv |
| 01 Dec 2025 | GIFT | CATALYST PHARMACEUTICALS, INC. | 45,000 | 0.00 USD | |
| 01 Dec 2025 | GIFT | CATALYST PHARMACEUTICALS, INC. | 45,000 | 0.00 USD | |
| 01 Dec 2025 | GIFT | CATALYST PHARMACEUTICALS, INC. | 45,000 | 0.00 USD | |
| 21 Nov 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,775 | — | |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 34,921 | 0.00 USD | deriv |
| 20 Nov 2025 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 10,540 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 1,775 | 0.00 USD | deriv |
| 09 Jun 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 171,748 | 26.11 USD | |
| 06 Jun 2025 | SALE | CATALYST PHARMACEUTICALS, INC. | 28,252 | 25.95 USD | |
| 09 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 3,533 | — | |
| 09 Dec 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 3,533 | 0.00 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 43,591 | 0.00 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | CATALYST PHARMACEUTICALS, INC. | 5,327 | 0.00 USD | deriv |
| 19 Nov 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 98,345 | 3.54 USD | |
| 19 Nov 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 98,345 | 21.19 USD | |
| 20 Nov 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 72,500 | 21.29 USD | |
| 20 Nov 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 72,500 | 3.54 USD | |
| 19 Nov 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 98,345 | 0.00 USD | deriv |
| 20 Nov 2024 | EXERCISE | CATALYST PHARMACEUTICALS, INC. | 72,500 | 0.00 USD | deriv |
| 13 Nov 2024 | SALE | CATALYST PHARMACEUTICALS, INC. | 92,500 | 22.98 USD |
2 purchases reported after at least 12 months of silence — most recent on 05 Sept 2017.